In the final Quarterly Review of 2021, we reflect on a year that has seen the UK acclimatise to life outside of the EU, whilst, like the rest of the world, contending with the difficulties brought on by the global coronavirus...more
12/15/2021
/ Anti-Bribery ,
Bribery ,
Coronavirus/COVID-19 ,
Credit Suisse ,
Deferred Prosecution Agreements ,
Financial Conduct Authority (FCA) ,
Financial Crimes ,
Fraud ,
Office of Financial Sanctions Implementation (OFSI) ,
Sanctions ,
Serious Fraud Office (SFO) ,
UK ,
UK Brexit
In our Quarterly Review, we bring you important UK developments relating to business crime, investigations, and regulatory enforcement from the last three months.
With this month marking half a year since the UK left the EU,...more
6/28/2021
/ Anti-Corruption ,
Autonomy ,
Bribery ,
Coronavirus/COVID-19 ,
Financial Crimes ,
Financial Services Act ,
Financial Services Industry ,
Ministry of Justice ,
Money Laundering ,
National Crime Agency (NCA) ,
Popular ,
Regulatory Agenda ,
Sanctions ,
Serious Fraud Office (SFO) ,
UK ,
UK Brexit
Nearly one year after its introduction to the House of Commons, the Medicines and Medical Devices Bill 2019‑2021 (the Bill) was granted Royal Assent on 11 February 2021, becoming law as the Medicines and Medical Devices Act...more
2/25/2021
/ Clinical Trials ,
Criminal Sanctions ,
EU ,
Life Sciences ,
Medical Devices ,
Medical Technology Companies ,
Medicines and Healthcare Products Regulatory Agency (MHRA) ,
Pharmaceutical Industry ,
Trade Agreements ,
UK ,
UK Brexit ,
UK Parliament